Antibody-based therapy for enterococcal catheter-associated urinary tract infections

mBio

Volumn 7, Issue 5, 2016, Pages

  Flores Mireles, Ana L ^a   Walker, Jennifer N ^a   Potretzke, Aaron ^a   Schreiber, Henry L ^a   Pinkner, Jerome S ^a   Bauman, Tyler M ^a   Park, Alyssa M ^a   Desai, Alana ^a   Hultgren, Scott J ^a   Caparon, Michael G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; EBPA N TERMINAL DOMAIN ANTIBODY; FIBRINOGEN; UNCLASSIFIED DRUG; ADHESIN; BACTERIUM ANTIBODY;

ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM ISOLATE; CATHETER ASSOCIATED URINARY TRACT INFECTION; CATHETER INFECTION; CATHETERIZATION; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF DETECTION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN BINDING; RENAL PROTECTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SINGLE DRUG DOSE; URINARY TRACT INFECTION; URINE SAMPLING; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; C57BL MOUSE; CATHETER-RELATED INFECTIONS; DISEASE MODEL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; TREATMENT OUTCOME; UNITED STATES; URINARY TRACT INFECTIONS;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; CATHETER-RELATED INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY; MICE, INBRED C57BL; TREATMENT OUTCOME; UNITED STATES; URINARY TRACT INFECTIONS;

EID: 84995576444     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01653-16     Document Type: Article

References (46)

1. Saint S, Wiese J, Amory JK, Bernstein ML, Patel UD, Zemencuk JK, Bernstein SJ, Lipsky BA, Hofer TP. 2000. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med 109: 476–480. http://dx.doi.org/10.1016/S0002-9343(00)00531-3.
2. Jain P, Parada JP, David A, Smith LG. 1995. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med 155:1425–1429.
3. de Oliveira Conterno L, Lobo JA, Masson W. 2011. The excessive use of urinary catheters in patients hospitalized in university hospital wards. Rev Esc Enferm USP 45:1089–1096. (In Portuguese.)
4. Parker D, Callan L, Harwood J, Thompson DL, Wilde M, Gray M. 2009. Nursing interventions to reduce the risk of catheter-associated urinary tract infection. Part 1: catheter selection. J Wound Ostomy Continence Nurs 36:23–34. http://dx.doi.org/10.1097/01.WON.0000345173.05376.3e.
5. Maki DG, Tambyah PA. 2001. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7:342–347. http://dx.doi.org/10.3201/eid0702.700342.
6. Willson M, Wilde M, Webb ML, Thompson D, Parker D, Harwood J, Callan L, Gray M. 2009. Nursing interventions to reduce the risk of catheter-associated urinary tract infection: Part 2: staff education, monitoring, and care techniques. J Wound Ostomy Continence Nurs 36: 137–154. http://dx.doi.org/10.1097/01.WON.0000347655.56851.04.
7. Tambyah PA, Maki DG. 2000. Catheter-associated urinary tract infection is rarely symptomatic—a prospective study of 1,497 catheterized patients. Arch Intern Med 160:678–682.
8. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE; Infectious Diseases Society of America. 2010. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 50:625–663.
9. Warren JW. 1997. Catheter-associated urinary tract infections. Infect Dis Clin North Am 11:609–622. http://dx.doi.org/10.1016/S0891-5520(05)70376-7.
10. Trautner BW, Darouiche RO. 2004. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med 164:842–850. http://dx.doi.org/10.1001/archinte.164.8.842.
11. Melzer M, Welch C. 2013. Outcomes in UK patients with hospitalacquired bacteraemia and the risk of catheter-associated urinary tract infections. Postgrad Med J 89:329–334. http://dx.doi.org/10.1136/postgradmedj-2012-131393.
12. Jarrell AS, Wood GC, Ponnapula S, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC. 2015. Short-duration treatment for catheter-associated urinary tract infections in critically ill trauma patients. J Trauma Acute Care Surg 79:649–653. http://dx.doi.org/10.1097/TA.0000000000000822.
13. Orsi GB, Ciorba V. 2013. Vancomycin resistant enterococci healthcare associated infections. Ann Ig 25:485–492.
14. Van Tyne D, Gilmore MS. 2014. Friend turned foe: evolution of enterococcal virulence and antibiotic resistance. Annu Rev Microbiol 68: 337–356. http://dx.doi.org/10.1146/annurev-micro-091213-113003.
15. Cardoso T, Ribeiro O, Aragão IC, Costa-Pereira A, Sarmento AE. 2012. Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort study. BMC Infect Dis 12: 375. http://dx.doi.org/10.1186/1471-2334-12-375.
16. Miller WR, Munita JM, Arias CA. 2014. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther 12:1221–1236. http://dx.doi.org/10.1586/14787210.2014.956092.
17. Arias CA, Murray BE. 2012. The rise of the enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10:266–278. http://dx.doi.org/10.1038/nrmicro2761.
18. Escaut L, Bouam S, Frank-Soltysiak M, Rudant E, Saliba F, Kassis N, Presiozi P, Vittecoq D. 2013. Eradication of an outbreak of vancomycinresistant enterococcus (VRE): the cost of a failure in the systematic screening. Antimicrob Resist Infect Contr 2:18. http://dx.doi.org/10.1186/2047-2994-2-18.
19. Byers KE, Anglim AM, Anneski CJ, Farr BM. 2002. Duration of colonization with vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol 23:207–211. http://dx.doi.org/10.1086/502036.
20. Team EE. 2013. CDC publishes report on antibiotic resistance threats in the United States for the first time. Euro Surveill 18:28.
21. Guiton PS, Hannan TJ, Ford B, Caparon MG, Hultgren SJ. 2013. Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections. Infect Immun 81:329–339. http://dx.doi.org/10.1128/IAI.00856-12.
22. Flores-Mireles AL, Walker JN, Bauman TM, Potretzke AM, Schreiber HL, Park AM, Pinkner JS, Caparon MG, Hultgren SJ, Desai A. 2016. Fibrinogen release and deposition on urinary catheters placed during urologic procedures. J Urol 196:416–421 http://dx.doi.org/10.1016/j.juro.2016.01.100.
23. Flores-Mireles AL, Pinkner JS, Caparon MG, Hultgren SJ. 2014. EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Sci Transl Med 6:254ra127. http://dx.doi.org/10.1126/scitranslmed.3009384.
24. Nallapareddy SR, Singh KV, Sillanpää J, Garsin DA, Höök M, Erlandsen SL, Murray BE. 2006. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J Clin Invest 116:2799–2807. http://dx.doi.org/10.1172/JCI29021.
25. Sillanpää J, Nallapareddy SR, Houston J, Ganesh VK, Bourgogne A, Singh KV, Murray BE, Höök M. 2009. A family of fibrinogen-binding MSCRAMMs from Enterococcus faecalis. Microbiology 155:2390–2400. http://dx.doi.org/10.1099/mic.0.027821-0.
26. Kau AL, Martin SM, Lyon W, Hayes E, Caparon MG, Hultgren SJ. 2005. Enterococcus faecalis tropism for the kidneys in the urinary tract of C57BL/6J mice. Infect Immun 73:2461–2468. http://dx.doi.org/10.1128/IAI.73.4.2461-2468.2005.
27. Nallapareddy SR, Murray BE. 2008. Role played by serum, a biological cue, in the adherence of Enterococcus faecalis to extracellular matrix proteins, collagen, fibrinogen, and fibronectin. J Infect Dis 197:1728–1736. http://dx.doi.org/10.1086/588143.
28. Shogan BD, Belogortseva N, Luong PM, Zaborin A, Lax S, Bethel C, Ward M, Muldoon JP, Singer M, An G, Umanskiy K, Konda V, Shakhsheer B, Luo J, Klabbers R, Hancock LE, Gilbert J, Zaborina O, Alverdy JC. 2015. Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak. Sci Transl Med 7:286ra268. http://dx.doi.org/10.1126/scitranslmed.3010658.
29. Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB. 2000. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 343: 1925–1932. http://dx.doi.org/10.1056/NEJM200012283432604.
30. Nielsen HV, Guiton PS, Kline KA, Port GC, Pinkner JS, Neiers F, Normark S, Henriques-Normark B, Caparon MG, Hultgren SJ. 2012. The metal ion-dependent adhesion site motif of the Enterococcus faecalis EbpA pilin mediates pilus function in catheter-associated urinary tract infection. mBio 3:e00177-12. http://dx.doi.org/10.1128/mBio.00177-12.
31. Lebreton F, Willems RJL, Gilmore MS. 2014. Enterococcus diversity, origins in nature, and gut colonization. In Gilmore MS, Clewell DB, Ike Y, Shankar N (ed), Enterococci: from commensals to leading causes of drug resistant infection. Massachusetts Eye and Ear Infirmary, Boston, MA.
32. Gilmore MS, Lebreton F, van Schaik W. 2013. Genomic transition of enterococci from gut commensals to leading causes of multidrug-resistant hospital infection in the antibiotic era. Curr Opin Microbiol 16:10–16. http://dx.doi.org/10.1016/j.mib.2013.01.006.
33. Guzmán Prieto AM, Urbanus RT, Zhang X, Bierschenk D, Koekman CA, van Luit-Asbroek M, Ouwerkerk JP, Pape M, Paganelli FL, Wobser D, Huebner J, Hendrickx AP, Bonten MJ, Willems RJ, van Schaik W. 2015. The N-terminal domain of the thermo-regulated surface protein PrpA of Enterococcus faecium binds to fibrinogen, fibronectin and platelets. Sci Rep 5:18255. http://dx.doi.org/10.1038/srep18255.
34. Guiton PS, Hung CS, Hancock LE, Caparon MG, Hultgren SJ. 2010. Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect Immun 78:4166–4175. http://dx.doi.org/10.1128/IAI.00711-10.
35. Guiton PS, Hung CS, Kline KA, Roth R, Kau AL, Hayes E, Heuser J, Dodson KW, Caparon MG, Hultgren SJ. 2009. Contribution of autolysin and sortase A during Enterococcus faecalis DNA-dependent biofilm development. Infect Immun 77:3626–3638. http://dx.doi.org/10.1128/IAI.00219-09.
36. Van Tyne D, Gilmore MS. 2014. A delicate balance: maintaining mutualism to prevent disease. Cell Host Microbe 16:425–427. http://dx.doi.org/10.1016/j.chom.2014.09.019.
37. Kinnebrew MA, Ubeda C, Zenewicz LA, Smith N, Flavell RA, Pamer EG. 2010. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant enterococcus infection. J Infect Dis 201:534–543. http://dx.doi.org/10.1086/650203.
38. Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ. 1997. Prevention of mucosal Escherichia coli infection by FimH-adhesion-based systemic vaccination. Science 276:607–611. http://dx.doi.org/10.1126/science.276.5312.607.
39. Jennewein C, Tran N, Paulus P, Ellinghaus P, Eble JA, Zacharowski K. 2011. Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med 17:568–573. http://dx.doi.org/10.2119/molmed.2010.00146.
40. Nomura R, Otsugu M, Naka S, Teramoto N, Kojima A, Muranaka Y, Matsumoto-Nakano M, Ooshima T, Nakano K. 2014. Contribution of the interaction of Streptococcus mutans serotype k strains with fibrinogen to the pathogenicity of infective endocarditis. Infect Immun 82: 5223–5234. http://dx.doi.org/10.1128/IAI.02164-14.
41. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193. http://dx.doi.org/10.1128/CMR.15.2.167-193.2002.
42. Finn RD, Clements J, Arndt W, Miller BL, Wheeler TJ, Schreiber F, Bateman A, Eddy SR. 2015. HMMER web server: 2015 update. Nucleic Acids Res 43:W30–W38. http://dx.doi.org/10.1093/nar/gkv397.
43. Finn RD, Clements J, Eddy SR. 2011. HMMER web server: interactive sequence similarity searching. Nucleic Acids Res 39:W29–W37. http://dx.doi.org/10.1093/nar/gkr367.
44. Cunningham F, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Girón CG, Gordon L, Hourlier T, Hunt SE, Janacek SH, Johnson N, Juettemann T, Kähäri AK, Keenan S, Martin FJ, Maurel T, McLaren W, Murphy DN, Nag R, Overduin B, Parker A, Patricio M, Perry E, Pignatelli M, Riat HS, Sheppard D, Taylor K, Thormann A, Vullo A, Wilder SP, Zadissa A, Aken BL, Birney E, Harrow J, Kinsella R, Muffato M, Ruffier M, Searle SM, Spudich G, Trevanion SJ, Yates A, Zerbino DR, Flicek P. 2015. Ensembl 2015. Nucleic Acids Res 43:D662–D669. http://dx.doi.org/10.1093/nar/gku1010.
45. Katoh K, Misawa K, Kuma K, Miyata T. 2002. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30:3059–3066. http://dx.doi.org/10.1093/nar/gkf436.
46. Suyama M, Torrents D, Bork P. 2006. PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments. Nucleic Acids Res 34:W609–W612. http://dx.doi.org/10.1093/nar/gkl315.